Yohay, S., Ying, G., Auckley, E., Aldakkak, M., Thalji, S. Z., Vakili, P., Grahl, J., Mayer, B., Shahjehan, F., Low, S. K., Evans, D. B., Christians, K. K., Seo, Y. D., Erickson, B., Hall, W. A., McFall, T., Kurzrock, R., George, B., Kamgar, M. (2025). MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12D or KRAS G12V alteration.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.726